part as the intact antibiotic, L-Cephaloglycin-uC is rapidly metabolized to L-2-phenylglycine-14C and its metabolites. In contrast to the results with dcephaloglycin-uC, no intact L-cephaloglycin-uC or deacetyl-L-cephaloglycin was excreted in the urine of rats.
D-Cephaloglycin is a broad spectrum antibiotic, active against gram-positive cocci, including penicillin-resistant strains, as well as against many gram-negative organisms15. Unlike many other members of this family of antibiotics, D-cephaloglycin is active when administered orally2).
In contrast to the D-isomer, L-cephaloglyein shows very limited activity in in vitro tests against Staphylococcus aureus.
As in previous studies on the fate of cephalosporin antibiotics from these laboratories3'^radiocarbon labeling has been used to facilitate the present investigation.
Materials and Methods d(-) and L(+)-2-Phenylglycine-uC. The procedure used for the preparation of racemic 2-phenylglycine-uC and its enzymatic resolution of its enantiomorphic forms has been described by Billings and Sullivan5) . D-Cephaloglycin-uC.
D-Phenylglycine-14C, 2.07 /!c/mg, was allowed to react with 5.0 m-moles of methyl acetoacetate in a solution consisting of 5.0 m-moles of sodium hydroxide, 0.35 ml of H2O and 2.0 ml of methanol. After heating for 30 minutes at 60°C, the clear reaction solution was evaporated to dryness in vacuo. The residual oil was dried for 24 hours in vacuo over concentrated sulfuric acid to yield semi-solid ; methyl 3-(d-#-carboxybenzylamino)crotonate-14C sodium salt.
Ethyl chloroformate (8.4 m-moles) was allowed to react with a solution consiting of
* In this paper the term D-cephaloglycin-uC is used to designate 7-(D-#-aminophenyl[l-uC] 5 m-moles of methyl 3-(D-<2-carboxybenzylamino)crotonate-14C sodium salt in 14 ml of acetonitrile containing one drop of N, N-dimethylbenzylamine at -10°C. After stirring the solution for 15 minutes at this temperature, a solution of 5 m-molesof 7-aminocephalosporanic acid6) in 12 ml of acetonitrile-water (1 : 1, v/v) containing 5 m-moles of triethylamine was added rapidly with stirring. After 30 minutes, 4.0 g of sodium chloride were added to the reaction mixture and stirring continued for 15 minutes at 0°C. The organic phase was separated and evaporated to dryness in vacuo. The residual oil was dissolved in 26 ml of isobutylmethyl ketone-water (10: 3, v/v) containing 1.5 ml of 99 % formic acid and the solution allowed to stand at 0°C for 18 hours to facilitate complete crystallization of the D-cephaloglycin-14C. The product was collected by centrifugation.
It was then suspended in 20 ml of acetonitrile and reisolated by centrifugation and dried in vacuo. The yield was 487 mg (24%) of pure D-cephaloglycin-14C with a specific radioactivity of 0.6 juC/mg. Paper chromatography followed by biological and radiological assay showed the product to be pure. L-Cephaloglycin-uC. Using the same procedure as described above, the L-enantiomer of cephaloglycin-14C was prepared from 5 m-moles of L-2-phenylglycine-14C having a specific radioactivity of 23 juC/mg. collected at regular intervals (2 hours) and feces samples were collected after 24 hours. The radioactivity contained in each urine sample was determined by liquid scintillation counting. The nature of the radiocarbon metabolites and the amountpresent in the urine was determined by paper chromatographic analysis of each sample. The biologically active metabolites were identified by comparison chromatography using authentic samples of cephaloglycin and deacetylcephaloglycin. Feces samples were dried, ground and analyzed for radiocarbon content by the Schoniger combustion method described by Kelly et al8). For the bile study, 200 g male rats were anesthetized with ether and a cannula placed in the common bile duct. The D-cephaloglycin-14C was adminitered orally and the bile fluid collected for 24 hours. Radiocarbon content was determined by liquid scintillation counting of an aliquot of the bile fluid. Blood level studies.
An aqueous solution of D-cephaloglycin-14C was administered intraperitoneally and orally to 200 g male Purdue-Wistar rats at a dose rate of 46 //moles/ kg. At given time intervals blood samples were removed from the tail vein. The samples, averaging 200 mg in weight, were placed in sausage-casing bags, dried for 48 hours and the radiocarbon content of each was determined by the Schoniger combustion method.
Results and Discussion
The presence of penicillin amidases or deacylating enzymes among fungi, yeasts and bacteria is well known9'10'n). These enzymes catalyze the hydrolysis of the sidechain amide moiety of many penicillins to yield the corresponding carboxylic acid and 6-amino-penicillanic acid. These enzymes show similar activity towards certain cephalosporin antibiotics12>13>14). Furthermore, the hydrolysis of the side-chain amide moiety of on the metabolism of the enantiomers of 2-phenylglycine16>17) leave some doubt as to the metabolic fate of these amino acids in the rat. A study of the metabolic fate of the isomers of 2-phenylglycine-14C in the rat was therefore carried out before work with the labeled antibiotics began.
Twenty-four hours after the intraperitoneal administration to rats of D-2-phenylglycine-14C, sodium salt (40 mg/kg), 79 % of the administered radiocarbon was recovered in the urine. Separation and identification of the radioactive metabolites by paper chromatography showed that 50 % of the administered dose appeared in the urine as unaltered D-2-phenylglycine-14G, 27 % as benzoylformic acid-14C and 2.0 % as mandelic acid-14C ( Table  1 ).
The total recovery of radiocarbon and the distribution of metabolites 24 hours, after the oral administration of 40 mg/kg of i)-2-phenylglycine-14G was very similar to> those obtained after intraperitoneal administration. The total recovery of radiocarbon in the urine accouted for 71 %of the administered dose. Unchanged D-phenylglycine-14C again was the major metabolite representing 41 % of the administered dose. Benzoylformic aeid-14G was the other major metabolite representing 30 % of the administered radiocarbon.
L-2-Phenylglycine-14C Table 1 also shows the total radiocarbon recovered and the distribution of labeled metabolites 24 hours following an intraperitoneal administration of 40 mg/kg of L-2-phenylglycine-14C. These results show that 89 % of the administered radiocarbon was. recovered in the urine of rats.
Benzoylformic acid-14C was the major metabolite accounting for 83.5 % of the administered dose. Trace amounts of mandelic acid-14G (3.7 %) and unchanged L-2-phenylglycine-14C (1.8 %) could be detected.
Oral administration of the L-2-phenylglycine-14G gave similar results. The total urinary radiocarbon amounted to 77 %of the administered dose and benzoylformic acid-14C again was the major radioactive metabolite representing 74.5 % of the admini- The results of this metabolism study showed first that oxidative deamination, as suggested by Neubauer16), was the major mechanism involved in the metabolism of the enatiomers of 2-phenylglycine-14C. The mandelic acid-14C isolated probably resulted from a small amount of enzymatic reduction of the deamination product, benzoylformic acid-14G. It is well known that mandelic acid is relatively stable in vivo and is largely excreted unchanged18).
Secondly there is a distinct difference in the metabolic stabilities of the enantiomers of this amino acid in the body. Thus the l(+) isomer is much more readily deaminated to benzoylformic acid than the r>(-) isomer. With the basic information available on the fate of the isomers of phenylglycine it nowbecame possible to proceed with a study of the metabolism of the isomers of cephaloglycin. Excretion Studies D-Cephaloglycin-14C. Fig. 1 shows the recovery of total urinary radioactivity as well as the distribution of radioactive metabolites in the urine following a single orally administered dose of D-cephaloglycin-uC to rats. Four percent of the administered radiocarbon had appeared in the urine after 4 hours, 12% in 12 hours and 20% in 24 hours. The feces collected over this 24-hour period were found to contain 70% of the administered dose. Cannulation of the bile duct prior to the administration of a single dose of D-cephaloglycin-14C and subsequent collection of a 24-hour sample of the bile fluid revealed that 8 % of the administered radiocarbon was eliminated by this route. Thus, most of the radioactivity appearing in the feces probably represents the drug or its degradation products. The separation of the radioactive metabolites in each urine sample was accomplished by use of paper chromatographic techniques. One biologically active metabolite was found in the urine and this was found during the first 8 hours. This metabolite was identified as deacetylcephaloglycin-14C and it represented 2 % of the administered dose. In addition to this metabolite, paper chromatography indicated the presence of four biologically inactive metabolites. The major metabolites were 2-phenylglycine-14C, hydrolysis of the side-chain amide moiety of the antibiotic. The total urinary radioactivity and distribution of radioactive metabolites after intraperitoneal administration of a single dose of D-cephaloglycin-uC to rats is shown in Fig. 2 . The recovery of radiocarbon in the urine was, as expected, much greater than that obtained after oral administration. After 1 hour, 38 % of the administered radioactivity had appeared in the urine, 59% after 4 hours and 71 %after 24 hours.
The major radioactive metabolites identified were the unchanged D-cephaloglycin-14C
(13.5 % of the administered radiocarbon) and D-deacetylcephaloglycin-14C (28.6 %). Other biologically inactive metabolites were : D-2-phenylglycine-uC (ll.3 %), benzoylformic acid-uC (7.8 %) , mandelic acid-uC (6.0 %) and an unknown uC-labeled polar metabolite (3.8 %) .
These results show that parenterally administered D-cephaloglycin is metabolized mainly by deacetylation to deacetylcephaloglycin. Some enzymatic hydrolysis of the 2-phenylglycine moiety did occur, however, as shown by the excretion of benzoylformic acid, 2-phenylglycine and mandelic acid. L~Cephaloglycin-14C. When this relatively inactive enantiomer of D-cephaloglycin-14G was administered intraperitoneally to rats, the excretion of metabolites was rapid (Fig. 3) . Sixty-five percent of the administered radioactivity had appeared in the urine during the first 4 hours and 71 % after 12 hours. Unlike its biologically active enantiomer, L-cephaloglycin-14C was rapidly metabolized in vivo. No evidence for the presence of unchanged antibiotic or its deacetyl derivative could be found in the urine. The 14C-labeled metabolites present in the urine were identified as : benzoylformic acid (75.5 %), mandelic acid (9.1 %), L-2-phenylglycine (6.2 %), and an unidentified polar metabolite (9.2%). This distribution of metabolites was reminiscent of that obtained earlier from the metabolism study of L-2-phenylglycine-uC. These results THE JOURNAL OF ANTIBIOTICS JAN. 1969 showed that the major route of metabolism of L-cephaloglycin-14C was by enzymatic hydrolysis of the side-chain amide grouping to produce L-2-phenylglycine-14C as the primary labeled metabolite.
After oral administration of L-cephaloglycin-uC to rats, 58 % of the administered radiocarbon was found in the urine after 24 hours. Like the intraperitoneal study no unchanged antibiotic or its deacetyl derivative could be found in the urine. The distribution of uG-labeled metabolites, i. e. benzoylformic acid (74.0 %), mandelic acid (6.0%), 2-phenylglycine (6.0%) and an unidentified polar metabolite (14.0 %), was similar to the distribution of metabolites obtained from the urine of rats after oral or intraperitoneal administration of L-2-phenylglycine-14C.
These results can be interpreted to mean that the L-cephaloglycin is substantially more sensitive to enzymatic hydrolysis than is D-cephaloglycin. This may explain its lack of microbiological activity. 
Whole Blood Radiocarbon Levels
The radiocarbon blood level curves obtained after intraperitoneal and oral administration of 46 //moles/kg of D-cephaloglycin-14C to rats are shown in Fig. 4 . Thirty minutes after intraperitoneal administration maximumradiocarbon levels equivalent to 7.5jug of antibiotic per milliliter of blood were obtained. Radiocarbon levels declined with a half-life of approximately 2~3 hours. Since the half-life of the parent drug appears to be extremely short it is reasonable to assume that most of the radiocarbon in the blood is in the form of deacetyl-D-cephaloglycin. The measured half-life of 2-3 hours is assumed to be the half-life of deacetyl-D-cephaloglycin. The peak blood level found 4 hours after oral administration of the antibiotic was much lower (0.85 juglg of blood).
The radiocarbon curves were bimodal in character indicating the presence of a longer half-lived uC-labeled metabolite in the blood. The level of this long-lived cephaloglycin-14C metabolite was quite low representing in this instance less than 0.1 %of the radioactive dose. Its half-life was of the order of 24 hours. The nature of this long-lived trace metabolite is unknown.
